Key facts
- This page summarizes Shriram Revankar's Form 4 filing for Dolby Laboratories, Inc. (DLB).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 May 2026, 17:31.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Tax liability
Additional SEC filing notes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Footnote F1
The shares were sold pursuant to a 10b5-1 trading plan adopted on August 22, 2025.
Footnote F2
Shares held following the reported transactions include 59,172 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
Footnote F3
Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
Footnote F4
In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units.
Footnote F5
Shares held following the reported transactions include 46,938 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.